COVID-19 (coronavirus) patients who were administered a novel antibody had fewer symptoms and were less likely to require hospitalization or emergency medical care than those who did not receive the antibody, according to a new study.
Home Science Clinical trial indicates monoclonal antibody lowered hospitalizations and emergency visits
Clinical trial indicates monoclonal antibody lowered hospitalizations and emergency visits
